QBiotics’ STELFONTA® Receives FDA Approval for Canine Mast cell Tumours
STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration’s Center for Veterinary Medicine for the treatment of non-metastatic mast cell tumours (MCT) in dogs, making it the first pharmaceutical treatment available for all grades of canine…
Comments Off on QBiotics’ STELFONTA® Receives FDA Approval for Canine Mast cell Tumours